Full-Time

Implementation Manager

Northeast

Confirmed live in the last 24 hours

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing technology provider

Healthcare

Compensation Overview

$100k - $120kAnnually

+ Commission + Stock Options

Junior, Mid

Boston, MA, USA + 1 more

More locations: New York, NY, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • BS, MS, or other relevant education in engineering or sciences
  • 3+ years of experience in a technical or clinical field with advanced degree, or 5+ years of equivalent work experience
  • Prior experience working in digital health, healthcare, or a regulated environment preferred
  • Knowledge in at least one of the following: Digital health technologies, Healthcare IT, such as PACS, EMR, CVIS, HIPAA requirements and PHI protections, Healthcare management, Relevant health industry experience for integrating new technologies
Responsibilities
  • Lead HeartFlow’s implementation process for integrating our technology into new customer accounts.
  • Manage implementation projects for new products or features to the commercial team and customers.
  • Provide end-user and commercial team training on HeartFlow products and CT data requirements to customers in accordance with specific training plans. Provide clinically-relevant and technical information and solutions in response to inquiries regarding use of HF technologies.
  • Document and track customer feedback, training, complaints, and resolutions in HeartFlow’s Customer Relationship Management system and help improve knowledge base for customer issues
  • Work with all internal stakeholders to improve the quality of customer support by studying, evaluating, and re-designing appropriate processes.
  • Understand issues, questions, and challenges of our customers and commercial team and help design and develop solutions, data insights, and tools to support commercial growth.
  • Respond to urgent, escalated technical issues from our customers or commercial team.
  • Field based position with up to 70% travel.

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, which have received FDA clearance and are available in the U.S., U.K., Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning. The goal is to improve cardiovascular care by making it safer and more efficient.

Company Stage

Series F

Total Funding

$858.5M

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

4%

1 year growth

16%

2 year growth

20%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $215 million Series F funding round led by Bain Capital Life Sciences positions HeartFlow for significant growth and expansion.
  • HeartFlow's AI-enabled products, such as the RoadMap Analysis, enhance diagnostic accuracy and efficiency, potentially improving patient outcomes and physician workflows.
  • With coverage by 100% of Medicare and over 98% of commercial payers, HeartFlow's technology is widely accessible, increasing its adoption and market penetration.

What critics are saying

  • The cardiovascular care market is highly competitive, requiring continuous innovation to maintain a leading position.
  • Regulatory hurdles and the need for ongoing FDA clearances could delay product launches and market entry.

What makes HeartFlow unique

  • HeartFlow's non-invasive cardiac test offers a safer and more efficient alternative to traditional invasive procedures, setting it apart in the cardiovascular care market.
  • The company's comprehensive product portfolio, including FFRCT, RoadMap, and Plaque Analysis, provides a unique combination of anatomical and physiological visualization of coronary arteries.
  • HeartFlow's technology has received FDA clearance and is commercially available in multiple countries, ensuring a broad market reach and regulatory credibility.

Help us improve and share your feedback! Did you find this helpful?